Editorial: Next generation γδ T cell-based tumor immunotherapy
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-09-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1041362/full |
| _version_ | 1811253767607156736 |
|---|---|
| author | Andy Hee-Meng Tan Alice Man Sze Cheung Alice Man Sze Cheung Dieter Kabelitz |
| author_facet | Andy Hee-Meng Tan Alice Man Sze Cheung Alice Man Sze Cheung Dieter Kabelitz |
| author_sort | Andy Hee-Meng Tan |
| collection | DOAJ |
| first_indexed | 2024-04-12T16:56:08Z |
| format | Article |
| id | doaj.art-e2387f44ed24463188790ad6ff13d3a5 |
| institution | Directory Open Access Journal |
| issn | 1664-3224 |
| language | English |
| last_indexed | 2024-04-12T16:56:08Z |
| publishDate | 2022-09-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj.art-e2387f44ed24463188790ad6ff13d3a52022-12-22T03:24:13ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-09-011310.3389/fimmu.2022.10413621041362Editorial: Next generation γδ T cell-based tumor immunotherapyAndy Hee-Meng Tan0Alice Man Sze Cheung1Alice Man Sze Cheung2Dieter Kabelitz3Immune Cell Manufacturing, Bioprocessing Technology Institute Agency for Science, Technology and Research (ASTAR), Singapore, SingaporeDepartment of Hematology, Singapore General Hospital, Singapore, SingaporeSingHealth Duke-National University of Singapore (NUS) Medicine Academic Clinical Programme, Singapore, SingaporeInstitute of Immunology, University of Kiel, Kiel, Germanyhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.1041362/fullgamma delta (γδ) T cellstumor immunotherapybutyrophilinscytokine programminggamma delta TCR repertoirecost-effective manufacturing of gamma delta t cell therapies |
| spellingShingle | Andy Hee-Meng Tan Alice Man Sze Cheung Alice Man Sze Cheung Dieter Kabelitz Editorial: Next generation γδ T cell-based tumor immunotherapy Frontiers in Immunology gamma delta (γδ) T cells tumor immunotherapy butyrophilins cytokine programming gamma delta TCR repertoire cost-effective manufacturing of gamma delta t cell therapies |
| title | Editorial: Next generation γδ T cell-based tumor immunotherapy |
| title_full | Editorial: Next generation γδ T cell-based tumor immunotherapy |
| title_fullStr | Editorial: Next generation γδ T cell-based tumor immunotherapy |
| title_full_unstemmed | Editorial: Next generation γδ T cell-based tumor immunotherapy |
| title_short | Editorial: Next generation γδ T cell-based tumor immunotherapy |
| title_sort | editorial next generation γδ t cell based tumor immunotherapy |
| topic | gamma delta (γδ) T cells tumor immunotherapy butyrophilins cytokine programming gamma delta TCR repertoire cost-effective manufacturing of gamma delta t cell therapies |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1041362/full |
| work_keys_str_mv | AT andyheemengtan editorialnextgenerationgdtcellbasedtumorimmunotherapy AT alicemanszecheung editorialnextgenerationgdtcellbasedtumorimmunotherapy AT alicemanszecheung editorialnextgenerationgdtcellbasedtumorimmunotherapy AT dieterkabelitz editorialnextgenerationgdtcellbasedtumorimmunotherapy |